1067 related articles for article (PubMed ID: 29310441)
41. Dihydromyricetin Improves Endothelial Dysfunction in Diabetic Mice via Oxidative Stress Inhibition in a SIRT3-Dependent Manner.
Hua YY; Zhang Y; Gong WW; Ding Y; Shen JR; Li H; Chen Y; Meng GL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933152
[TBL] [Abstract][Full Text] [Related]
42. Estrogen Signals Through Peroxisome Proliferator-Activated Receptor-γ Coactivator 1α to Reduce Oxidative Damage Associated With Diet-Induced Fatty Liver Disease.
Besse-Patin A; Léveillé M; Oropeza D; Nguyen BN; Prat A; Estall JL
Gastroenterology; 2017 Jan; 152(1):243-256. PubMed ID: 27658772
[TBL] [Abstract][Full Text] [Related]
43. OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease.
Akie TE; Liu L; Nam M; Lei S; Cooper MP
PLoS One; 2015; 10(5):e0125617. PubMed ID: 25933096
[TBL] [Abstract][Full Text] [Related]
44. Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice.
Liou CJ; Wei CH; Chen YL; Cheng CY; Wang CL; Huang WC
Cell Physiol Biochem; 2018; 49(5):1870-1884. PubMed ID: 30235452
[TBL] [Abstract][Full Text] [Related]
45. Elucidation of SIRT-1/PGC-1α-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease.
Jiang Y; Chen D; Gong Q; Xu Q; Pan D; Lu F; Tang Q
Lipids Health Dis; 2021 Apr; 20(1):40. PubMed ID: 33902605
[TBL] [Abstract][Full Text] [Related]
46. Taurine attenuates the development of hepatic steatosis through the inhibition of oxidative stress in a model of nonalcoholic fatty liver disease in vivo and in vitro.
Murakami S; Ono A; Kawasaki A; Takenaga T; Ito T
Amino Acids; 2018 Sep; 50(9):1279-1288. PubMed ID: 29946793
[TBL] [Abstract][Full Text] [Related]
47. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
[TBL] [Abstract][Full Text] [Related]
48. Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression.
Bellanti F; Villani R; Tamborra R; Blonda M; Iannelli G; di Bello G; Facciorusso A; Poli G; Iuliano L; Avolio C; Vendemiale G; Serviddio G
Redox Biol; 2018 May; 15():86-96. PubMed ID: 29220698
[TBL] [Abstract][Full Text] [Related]
49. Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3.
He J; Hu B; Shi X; Weidert ER; Lu P; Xu M; Huang M; Kelley EE; Xie W
Mol Cell Biol; 2013 May; 33(10):2047-55. PubMed ID: 23508103
[TBL] [Abstract][Full Text] [Related]
50. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction.
Boland ML; Oldham S; Boland BB; Will S; Lapointe JM; Guionaud S; Rhodes CJ; Trevaskis JL
World J Gastroenterol; 2018 Apr; 24(16):1748-1765. PubMed ID: 29713129
[TBL] [Abstract][Full Text] [Related]
51. The PDE5 inhibitor udenafil ameliorates nonalcoholic fatty liver disease by improving mitochondrial function.
Yu HM; Chung HK; Park KS
Biochem Biophys Res Commun; 2021 Jun; 558():57-63. PubMed ID: 33895552
[TBL] [Abstract][Full Text] [Related]
52. Isosteviol Protects Free Fatty Acid- and High Fat Diet-Induced Hepatic Injury
Yi H; Xu D; Wu X; Xu F; Lin L; Zhou H
Antioxid Redox Signal; 2019 Jun; 30(17):1949-1968. PubMed ID: 30484323
[No Abstract] [Full Text] [Related]
53. Protective effect of metformin against palmitate-induced hepatic cell death.
Geng Y; Hernández Villanueva A; Oun A; Buist-Homan M; Blokzijl H; Faber KN; Dolga A; Moshage H
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165621. PubMed ID: 31786336
[TBL] [Abstract][Full Text] [Related]
54. Theacrine protects against nonalcoholic fatty liver disease by regulating acylcarnitine metabolism.
Wang GE; Li YF; Zhai YJ; Gong L; Tian JY; Hong M; Yao N; Wu YP; Kurihara H; He RR
Metabolism; 2018 Aug; 85():227-239. PubMed ID: 29727630
[TBL] [Abstract][Full Text] [Related]
55. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway.
Zhang YP; Deng YJ; Tang KR; Chen RS; Liang S; Liang YJ; Han L; Jin L; Liang ZE; Chen YN; Yang QH
Curr Med Sci; 2019 Feb; 39(1):37-43. PubMed ID: 30868489
[TBL] [Abstract][Full Text] [Related]
56. Troxerutin improves hepatic lipid homeostasis by restoring NAD(+)-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice.
Zhang ZF; Fan SH; Zheng YL; Lu J; Wu DM; Shan Q; Hu B
Biochem Pharmacol; 2014 Sep; 91(1):74-86. PubMed ID: 25026599
[TBL] [Abstract][Full Text] [Related]
57. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
58. Western Diet Decreases the Liver Mitochondrial Oxidative Flux of Succinate: Insight from a Murine NAFLD Model.
Staňková P; Kučera O; Peterová E; Elkalaf M; Rychtrmoc D; Melek J; Podhola M; Zubáňová V; Červinková Z
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34199098
[TBL] [Abstract][Full Text] [Related]
59. SIRT3-SOD2-mROS-dependent autophagy in cadmium-induced hepatotoxicity and salvage by melatonin.
Pi H; Xu S; Reiter RJ; Guo P; Zhang L; Li Y; Li M; Cao Z; Tian L; Xie J; Zhang R; He M; Lu Y; Liu C; Duan W; Yu Z; Zhou Z
Autophagy; 2015; 11(7):1037-51. PubMed ID: 26120888
[TBL] [Abstract][Full Text] [Related]
60. Metformin reduces hepatic expression of SIRT3, the mitochondrial deacetylase controlling energy metabolism.
Buler M; Aatsinki SM; Izzi V; Hakkola J
PLoS One; 2012; 7(11):e49863. PubMed ID: 23166782
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
